Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chimeric Antigen Receptor (CAR) Cell Therapy Related Cardiovascular Outcomes

NCT05130489 is registered in ClinicalTrials.gov with University College London Hospitals as lead sponsor.

NCT NCT05130489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05130489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chimeric Antigen Receptor (CAR) Cell Therapy Related Cardiovascular Outcomes
Lead sponsor
University College London Hospitals
Phase
Observational
Overall status
Completed
Start date
January 18, 2021
Completion date
May 1, 2023
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell acute lymphoblastic leukemia, b-cell lymphoma recurrent, b-cell lymphoma refractory, cardiotoxicity, cardiovascular complication, cardiovascular diseases, diffuse large b cell lymphoma, primary mediastinal large b-cell lymphoma (pmbcl)